Viewing Study NCT06763692


Ignite Creation Date: 2025-12-24 @ 3:50 PM
Ignite Modification Date: 2025-12-24 @ 3:50 PM
Study NCT ID: NCT06763692
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-03-25
First Post: 2025-01-03
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Low Intensity Focused Ultrasound for Parkinson's Disease
Sponsor: Ali Rezai
Organization:

Study Overview

Official Title: Early Feasibility Study of Low-Intensity Focused Ultrasound (LIFU) Neuromodulation in Patients with Parkinson's Disease
Status: NOT_YET_RECRUITING
Status Verified Date: 2025-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study is a prospective, single-center, single-arm early feasibility study, to establish safety and tolerability of LIFU for neuromodulation in patients with parkinson's Disease
Detailed Description: The primary objective is to evaluate the safety, feasibility and tolerability of LIFU as an adjunct neuromodulatory treatment for Parkinson's Disease

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: True
Is an Unapproved Device?: True
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: